Perennial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.39M Sell
56,098
-7,874
-12% -$635K 0.68% 45
2026
Q1
$5.54M Buy
63,972
+2,140
+3% +$205K 0.94% 37
2025
Q4
$5.94M Buy
61,832
+2,861
+5% +$278K 1% 34
2025
Q3
$5.62M Buy
58,971
+375
+0.6% +$34.5K 0.97% 35
2025
Q2
$5.11M Sell
58,596
-822
-1% -$69.7K 0.95% 36
2025
Q1
$5.34M Sell
59,418
-878
-1% -$78.6K 1.07% 34
2024
Q4
$4.82M Buy
+60,296
New +$5.22M 1.05% 33
2024
Q2
$4.75M Buy
60,283
+1,750
+3% +$143K 1.06% 34
2024
Q1
$5.1M Buy
58,533
+1,127
+2% +$96.2K 1.19% 31
2023
Q4
$4.73M Sell
57,406
-1,351
-2% -$103K 1.16% 34
2023
Q3
$4.6M Sell
58,757
-104
-0.2% -$8.71K 1.24% 32
2023
Q2
$5.19M Buy
58,861
+931
+2% +$80.2K 1.32% 29
2023
Q1
$4.67M Buy
57,930
+2,173
+4% +$177K 1.34% 31
2022
Q4
$4.33M Sell
55,757
-1,185
-2% -$96K 1.38% 34
2022
Q3
$4.6M Buy
56,942
+441
+0.8% +$39.6K 1.51% 27
2022
Q2
$5.07M Buy
56,501
+1,500
+3% +$152K 1.58% 29
2022
Q1
$6.1M Buy
55,001
+840
+2% +$88.7K 1.62% 30
2021
Q4
$5.6M Buy
54,161
+2,260
+4% +$262K 1.51% 32
2021
Q3
$6.51M Buy
51,901
+1,339
+3% +$173K 1.92% 23
2021
Q2
$6.28M Buy
50,562
+2,602
+5% +$327K 1.82% 24
2021
Q1
$5.67M Buy
47,960
+421
+0.9% +$49.3K 1.78% 26
2020
Q4
$5.57M Buy
47,539
+724
+2% +$79.7K 1.96% 20
2020
Q3
$4.87M Buy
46,815
+803
+2% +$80.6K 1.99% 21
2020
Q2
$4.22M Buy
46,012
+1,331
+3% +$128K 1.79% 23
2020
Q1
$4.03M Buy
44,681
+4,181
+10% +$445K 2.24% 16
2019
Q4
$4.59M Sell
40,500
-147
-0.4% -$16.1K 2.21% 14
2019
Q3
$4.42M Buy
40,647
+784
+2% +$81.8K 2.29% 14
2019
Q2
$3.88M Buy
39,863
+1,947
+5% +$178K 2.07% 18
2019
Q1
$3.45M Buy
37,916
+2,096
+6% +$188K 1.96% 19
2018
Q4
$3.26M Buy
35,820
+2,558
+8% +$239K 2.11% 16
2018
Q3
$3.27M Sell
33,262
-178
-0.5% -$16.5K 1.88% 21
2018
Q2
$2.86M Buy
33,440
+122
+0.4% +$10.2K 1.77% 21
2018
Q1
$2.67M Sell
33,318
-1,591
-5% -$131K 1.69% 26
2017
Q4
$2.82M Sell
34,909
-128
-0.4% -$10.3K 1.75% 24
2017
Q3
$2.73M Buy
35,037
+3,681
+12% +$306K 1.84% 21
2017
Q2
$2.78M Buy
31,356
+3,084
+11% +$260K 2.02% 16
2017
Q1
$2.28M Buy
28,272
+2,094
+8% +$164K 1.75% 24
2016
Q4
$1.86M Buy
+26,178
New +$2.06M 1.55% 26

Other funds holding MDT

Perennial Advisors's MDT Position: Q2 2026 in Review

Perennial Advisors reduced its Medtronic (MDT) stake by 12% in Q2 2026, selling an estimated $635K and leaving 56,098 shares worth $4.39M. The position accounts for 0.68% of the portfolio, ranked #45.

Perennial Advisors first reported a position in MDT in Q4 2016 and has held it in 38 quarters since. The position peaked at $6.51M in Q3 2021. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Perennial Advisors held 56,098 shares of Medtronic worth $4.39M as of Q2 2026.
  • Perennial Advisors sold 7,874 Medtronic shares in Q2 2026, an estimated $635K.
  • Medtronic made up 0.68% of Perennial Advisors's portfolio in Q2 2026, its #45 holding.
  • Perennial Advisors first reported a position in Medtronic in Q4 2016 and has held it in 38 quarters since.
  • Perennial Advisors's Medtronic position peaked at $6.51M in Q3 2021.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Perennial Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.